3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Leukemia, Lymphocytic, Chronic, B-Cell
15
Lymphoma, Non-Hodgkin
14
Leukemia, Myeloid, Acute
14
Burkitt Lymphoma
14
Lymphoma, Mantle-Cell
13
Lymphoma, Large B-Cell, Diffuse
13
Lymphoma, Follicular
13
Lymphoma, B-Cell, Marginal Zone
13
Hodgkin Disease
13
Lymphoma, Large-Cell, Immunoblastic
12
Multiple Myeloma
11
Leukemia, Myeloid, Chronic-Phase
11
Blast Crisis
11
Lymphoma, T-Cell, Cutaneous
10
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
10
Leukemia, Myeloid, Accelerated Phase
10
Leukemia, Hairy Cell
10
Leukemia
10
Leukemia, Myelomonocytic, Chronic
9
Congenital Abnormalities
9
Sezary Syndrome
8
Mycosis Fungoides
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Myeloproliferative Disorders
7
Lymphoma
7
Waldenstrom Macroglobulinemia
6
Primary Myelofibrosis
6
Neoplasms
6
Lymphoma, Large-Cell, Anaplastic
6
Interventions
Tretinoin
1
Therapeutics
1
Restraint, Physical
1
Nutritional Support
1
Geriatric Assessment
1
Exercise
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Frailty
×
Therapeutics
×
Other hematologic neoplasm
×
Clear all
NCT06373471
2024-04-18
IMPROVE
Odense University Hospital
Phase NA
Recruiting
152 enrolled